Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H15NO |
| Molecular Weight | 177.2429 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N)CC1=CC2=C(OCC2)C=C1
InChI
InChIKey=PZTJXZKNTPCPJL-UHFFFAOYSA-N
InChI=1S/C11H15NO/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11/h2-3,7-8H,4-6,12H2,1H3
| Molecular Formula | C11H15NO |
| Molecular Weight | 177.2429 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:45:13 UTC 2023
by
admin
on
Sat Dec 16 06:45:13 UTC 2023
|
| Record UNII |
UI10BAJ8SH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-5-APDB
Created by
admin on Sat Dec 16 06:45:13 UTC 2023 , Edited by admin on Sat Dec 16 06:45:13 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70934560
Created by
admin on Sat Dec 16 06:45:13 UTC 2023 , Edited by admin on Sat Dec 16 06:45:13 UTC 2023
|
PRIMARY | |||
|
152624-03-8
Created by
admin on Sat Dec 16 06:45:13 UTC 2023 , Edited by admin on Sat Dec 16 06:45:13 UTC 2023
|
PRIMARY | |||
|
UI10BAJ8SH
Created by
admin on Sat Dec 16 06:45:13 UTC 2023 , Edited by admin on Sat Dec 16 06:45:13 UTC 2023
|
PRIMARY | |||
|
5-APDB
Created by
admin on Sat Dec 16 06:45:13 UTC 2023 , Edited by admin on Sat Dec 16 06:45:13 UTC 2023
|
PRIMARY | 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes.[1] It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge.[1] 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead.[1] 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA.[1] | ||
|
192601
Created by
admin on Sat Dec 16 06:45:13 UTC 2023 , Edited by admin on Sat Dec 16 06:45:13 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
